Ask AI
EBC IDST
Interactive Decision Support Tool: Selecting Systemic Therapy for Early Breast Cancer

Released: August 07, 2026

Instructions

This Interactive Decision Support Tool provides treatment recommendations from 5 experts based on the specific patient and disease characteristics you enter in the tool. It is recommended that you have as much information as possible available before you begin.

You will be prompted to provide specific information about your patient including breast cancer type, tumor stage, tumor size, risk category including actionable biomarker status (eg, BRCA1 or BRCA2), and comorbidities that might impact treatment selection such as heart disease, diabetes and/or neuropathy, renal function, gastrointestinal disease, autoimmune disease, psychiatric condition, and history of pneumonitis.

Click on your selections. Your choices can be changed at any time simply by selecting the [change] icon by the question you want to change and entering a new choice.

Additional information on each variable/characteristic and why it is important for making management decisions is available by clicking on the [i] icon after each selection.

When all patient characteristics are entered, you will be asked to select the management option you are currently planning. Once that information is entered, you can click on Submit Patient Case to view the expert recommendations.

After reviewing your case-specific recommendations, you will be asked brief questions about how the recommendations influenced your decision-making. You will then be able to enter a new case scenario by clicking the Start New Case button.

When viewing the tool on the Decera Clinical Education website, you will also have the following options:

  • Print/download the recommendations along with a summary of the patient characteristics and selected therapy you entered by clicking the Case Summary button

Note: The current tool was developed in July 2026 and reflects the expert recommendations at that time.

Access to and use of this Interactive Decision Support Tool titled, “Interactive Decision Support Tool: Selecting Systemic Therapy for Early Breast Cancer” is provided subject to the following terms and conditions. PLEASE READ THESE TERMS CAREFULLY.

This Interactive Decision Support Tool is designed to educate healthcare professionals on making optimal management choices for patients with early-stage HR-positive/HER2-negative, HER2-positive, and triple-negative breast cancer (TNBC). The information provided is based on guideline recommendations and expert guidance of Shipra Gandhi, MD, MS; Tanya Gupta, MD; Reshma L. Mahtani, DO; Erica L. Mayer, MD, MPH; and Laura Spring, MD. The material published by Decera Clinical Education reflects the views of the reviewers or authors of the Decera Clinical Education material, not those of Decera Clinical Education, LLC, the accredited provider, or the companies providing educational grants. The materials may discuss uses and dosages for therapeutic products that have not been approved by the FDA. A qualified healthcare professional should be consulted before using any therapeutic product discussed. Readers should verify all information and data before treating patients or using any therapies described in these materials.

Although the information contained in the “Interactive Decision Support Tool: Selecting Systemic Therapy for Early Breast Cancer” Interactive Decision Support Tool has been produced and processed from sources believed to be reliable, no warranty, expressed or implied, is made regarding the accuracy, adequacy, completeness, legality, reliability, or usefulness of any information. This disclaimer applies to both the isolated and aggregate uses of the information. Decera Clinical Education provides this information on an as-is basis. This disclaimer applies to all material published by Decera Clinical Education, including but not limited to medical information or opinions. All warranties of any kind, expressed or implied, including but not limited to the implied warranties of merchantability, fitness for a particular purpose, freedom from contamination by computer viruses, and noninfringement of proprietary rights are disclaimed.

Any trademarks are the property of respective companies.

©2026 Decera Clinical Education, LLC. All rights reserved.

Program Content